Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Surgical Treatment for Cervical Esophageal Cancer

경부식도암에 대한 수술적 치료

  • Kim, Dae-Hyun (East-Wese Neo Medical Center, Kyung Hee University, Department of Thoracic and Cardiovascular Surgery) ;
  • Baek, Hee-Jong (Department of Thoracic Surgery, Korea Cancer Center Hospital) ;
  • Lee, Hae-Won (Department of Thoracic Surgery, Korea Cancer Center Hospital) ;
  • Park, Jong-Ho (Department of Thoracic Surgery, Korea Cancer Center Hospital)
  • 김대현 (경희대학교 동서신의학병원 흉부외과학교실) ;
  • 백희종 (원자력병원 흉부외과) ;
  • 이해원 (원자력병원 흉부외과) ;
  • 박종호 (원자력병원 흉부외과)
  • Published : 2008.04.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The incidence of cervical esophageal cancer is low compared with that of thoracic esophageal cancer, and the role of surgery for cervical esophageal cancer is limited compared with that of radiotherapy or chemotherapy. This study was carried out to determine the outcome of surgery for cervical esophageal cancer. Material and Method: We analyzed retrospectively medical records of 43 patients who had undergone curative surgical resection for cervical esophageal cancer from January 1989 to December 2002. Follow-up loss was absent and the last follow-up was carried out in February 28, 2004. Result: The mean age was 60 years old and the male to female ratio was 40:3. Histologic types were squamous cell carcinoma 42 patients and malignant melanoma 1 patient. The methods used for esophageal reconstruction were gastric pull-up 32 patients, free jejunal graft 7 patients and colon interposition 4 patients. Postoperative complications occurred in 31 patients (72%), and operative mortality occurred in 7 patients (16%). Pathologic stages were I 3, IIa 14, IIb 1, III 19, and IVa 6 patients. Tumor recurrence occurred in 16 patients (44%), and the 3 and 5-year survival rates were 29.3% and 20.9%. Conclusion: The reported surgical results for cervical esophageal cancer showed somewhat high operative mortality, postoperative complication rates and recurrence rates and a low long-term survival rate. It is suggested that multimodality treatment including surgery is needed for the treatment of cervical esophageal cancer because radiotherapy or chemotherapy without surgery could not relieve dysphagia or resolve the tumor completely.

배경: 경부식도암은 흉부식도암에 비해 발생 빈도가 상대적으로 낮고 방사선치료나 항암 약물치료의 역할이 흉부식도암에서보다 상대적으로 높다. 따라서 경부식도암에 대한 수술적 치료의 역할이 흉부식도암에 비해 상대적으로 제한적이다. 저자들은 경부식도암에 대한 수술적 치료의 결과를 알아보기 위해 본 연구를 시행하였다. 대상 및 방법: 1989년 1월부터 2002년 12월까지 경부식도암(경흉부식도 암 포함 )으로 수술을 시행 받은 환자 43명의 결과를 후향적으로 분석하였다. 모든 환자에서 추적이 가능하였으며, 최종 추적일은 2004년 2월 28일이었다. 결과: 대상 환자의 평균 나이는 60세$(43{\sim}77)$였고, 남녀 비는 40:3이었다. 조직학적으로 편평상피세포암이 42명, 악성 흑색종이 1명이었다. 식도 재건 방법은 gastric pull-up 32명, 유리 공장 이식 7명, colon interposition 4명이었다. 전체 43명 중 31명(72%)의 환자에서 합병증이 발생하였고, 수술 사망자는 7명(16%)이었다. 수술 후 최종 병기는 I 3명, IIa 14 명, IIb 1명, III 19명, IVa 6명이었다. 수술 사망자를 제외한 36 명 중 16명(44%)에서 종양이 재발하였고, 수술 후 3년, 5년 생존율은 29.3% 와 20.9%이었다. 결론: 경부식도암에 대한 수술은 수술 사망률, 합병증 발생률, 재발률이 높고, 장기 생존율이 낮지만, 방사선치료나 항암약물치료 만으로는 연하곤란의 완전한 해소 및 종양의 완치가 어려우므로 수술이 포함되는 다방법 병합치료가 필요하다고 생각한다.

Keywords

References

  1. Laterza E, Mosciaro O, Urso US, Inaspettato G, Cordiano C. Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy. Hepatogastroenterology 1994;41:278-282
  2. Marmuse JP, Koka VN, Guedon C, Benhamou G. Surgical treatment of carcinoma of the proximal esophagus. Am J Surg 1995;169:386-390 https://doi.org/10.1016/S0002-9610(99)80182-2
  3. Peracchia A, Bardini R, Roul A, et al. Surgical management of carcinoma of the hypopharynx and cervical esophagus. Hepatogastroenterology 1990;37:371-375
  4. Langer M, Choi NC, Orlow E, Grillo H, Wilkins EW. Radiation therapy alone or in combination with surgery in the treatment of carcinoma of the esophagus. Cancer 1986;58:1208-1213 https://doi.org/10.1002/1097-0142(19860915)58:6<1208::AID-CNCR2820580606>3.0.CO;2-1
  5. Sugarbaker DJ, Decamp MM. Selecting the surgical approach to cancer of the esophagus. Chest 1993;103:410-414 https://doi.org/10.1378/chest.103.2.410
  6. Ong GB, Lee TC. Pharyngogastric anastomosis after oesophago-pharyngectomy for carcinoma of the hypopharynx and cervical oesophagus. Br J Surg 1960;48:193-200 https://doi.org/10.1002/bjs.18004820823
  7. Triboulet JP, Mariette C, Chevalier D, Amrouni H. Surgical management of carcinoma of the hypopharynx and cervical esophagus. Arch Surg 2001;136:1164-1170 https://doi.org/10.1001/archsurg.136.10.1164
  8. Wei WI, Lam LK, Yuen PW, Wong J. Current status of pharyngolaryngo-esophagectomy and pharyngogastric anastomosis. Head Neck 1998;20:240-244 https://doi.org/10.1002/(SICI)1097-0347(199805)20:3<240::AID-HED9>3.0.CO;2-0
  9. Spiro RH, Bains MS, Shah JP, Strong EW. Gastric transposition for head and neck cancer: a critical update. Am J Surg 1991;162:348-352 https://doi.org/10.1016/0002-9610(91)90146-5
  10. Davis PA, Law S, Wong J. Colonic interposition after esophagectomy for cancer. Arch Surg 2003;138:303-308 https://doi.org/10.1001/archsurg.138.3.303
  11. DeMeester SR. Colon interposition following esophagectomy. Dis Esophagus 2001;14:169-172 https://doi.org/10.1046/j.1442-2050.2001.00180.x
  12. Chen HC, Tang YB. Microsurgical reconstruction of the esophagus. Semin Surg Oncol 2000;19:235-245 https://doi.org/10.1002/1098-2388(200010/11)19:3<235::AID-SSU5>3.0.CO;2-M
  13. Kim HY, Cho JI, Shim YM. Pharyngeal and esophageal reconstruction with free jejunal greaf. Korean J Thorac Cardiovasc Surg 1994;27:140-147
  14. Schultz-Coulon HJ. Jejunum interposition after cervical esophageal resection. Dis Esophagus 2001;14:13-16 https://doi.org/10.1111/j.1442-2050.2001.00144.x
  15. Lam KH, Choi TK, Wei WI, Lau WF, Wong J. Present status of pharyngogastric anastomosis following pharyngolaryngo-oesophagectomy. Br J Surg 1987;74:122-125 https://doi.org/10.1002/bjs.1800740218
  16. Pradhan SA, Rajpal RM. Gastric pull-up for cancers of the hypopharynx and cervical esophagus: our experience. J Surg Oncol 1984;26:149-152 https://doi.org/10.1002/jso.2930260215
  17. Orringer MB. Multimodality therapy for esophageal carcinoma-update. Chest 1993;103:406-409 https://doi.org/10.1378/chest.103.4_Supplement.406S
  18. Bonavina L, Botturi M, Pagani M, Via A, Saino G. Current status of surgery for carcinoma of the hypopharynx and cervical esophagus. Dis Esophagus 2001;14:95-97 https://doi.org/10.1046/j.1442-2050.2001.00163.x
  19. Urschel JD, Ashiku S, Thurer R, Sellke FW. Salvage or planned esophagectomy after chemoradiation therapy for locally advanced esophageal cancer. a review. Dis Esophagus 2003;16:60-65 https://doi.org/10.1046/j.1442-2050.2003.00296.x
  20. Swisher SG, Wynn P, Putnam JB, et al. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 2002;123: 175-183 https://doi.org/10.1067/mtc.2002.119070